Non-competitive binding of the nonpeptide antagonist BIBP3226 to rat forebrain neuropeptide Y1 receptors

European Journal of Pharmacology

Volumn 331, Issue 2-3, 1997, Pages 275-284

  Vanderheyden, Patrick M L ^a   Van Liefde, Isabelle ^a   De Backer, Jean Paul ^a   Vauquelin, Georges ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

BIBP3226; Brain, rat; Neuropcptide Y Y1 receptor; Neuropeptide Y; Radioligand binding

Indexed keywords

NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y [18-36]; NEUROPEPTIDE Y DERIVATIVE; NEUROPEPTIDE Y1 RECEPTOR; PEPTIDE YY; SR 120107; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FOREBRAIN; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY;

ANIMALS; ARGININE; BINDING, COMPETITIVE; GUANYLYL IMIDODIPHOSPHATE; HALF-LIFE; MEMBRANES; NERVE TISSUE PROTEINS; NEUROPEPTIDE Y; PROSENCEPHALON; PROTEINS; RADIOLIGAND ASSAY; RATS; RECEPTORS, NEUROPEPTIDE Y;

EID: 0030837711     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01016-9     Document Type: Article

References (49)

1. 1 antagonist BIBP 3226. Br. J. Pharmacol. 116, 2245-2250.
2. 4 subtype receptor for pancreatic polypeptide, neuropeptide Y, and peptide YY. J. Biol. Chem. 270, 26762-26765.
3. Birnbaumer, L., Birnbaumer, M., 1995. Signal transduction by G proteins: 1994 edition. J. Recept. Signal Transduction Res. 15, 213-252.
4. Busch-Sorensen, M., Peikh, S.H., O'Hare, M., Tortoa, O., Schwartz, T.W., Gammeltoft, S., 1989. Regional distribution of neuropeptide Y and its receptor in the porcine central nervous system. J. Neurochem. 52, 1545.
5. 2-adrenergic receptors. Mol. Pharmacol. 32, 65-1152.
6. 3H]neuropeptide Y binding. Neurochem. Int. 29, 669-676.
7. De Chaffoy de Courcelles, D., Leysen, J.E., Roevens, P., Van Belle, H., 1986. The serotonin-S2 receptor: A receptor, transducer coupling model to explain insurmountable antagonist effects. Drug Dev. Res. 8, 173-178.
8. De Lean, A., Stadel, J.M., Lefkowitz, R.J., 1980. A ternary complex model explains the agonist-specific properties of the adenylate cyclase-coupled α adrenergic receptor. J. Biol. Chem. 255, 7108-7117.
9. 2 receptors in the rat brain. J. Pharmacol. 191, 501-503.
10. Dumont, Y., Fournier, A., St-Pierre, S., Quirion, R., 1993. Comparative characterization and autoradiographic distribution of neuropeptide Y receptor subtypes in the rat brain. J. Neurosci. 13, 73-86.
11. Doods, H.N., Wienen, W., Entzeroth, M., Rudolf, K., Eberlein, W., Engel, W., Wieland, H.A., 1995. Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP3226. J. Pharmacol. Exp. Ther. 275, 136-142.
12. 3H]BIBP3226. Eur. J. Pharmacol. 278, 239-242.
13. Evequoz, D., Grouzmann, E., Beck Sickinger, A.G., Brunner, H.R., Waeber, B., 1994. Differential vascular effects of neuropeptide Y (NPY) selective receptor agonists. Experientia 50, 936-938.
14. 2 receptor subtype. J. Biol. Chem. 270, 26758-26761.
15. Gerald, C., Walker, M.W., Criscione, L., Gustafson, E.L., Batzl-Hartmann, C., Smith, K.E., Vaysse, P., Durkin, M.M., Laz, T.M., Linemeyer, D.L., Schaffhauser, A.O., Whitebreadt, S., Hofbauer, K.G., Taber, R.I., Branchek, T.A., Weinshank, R.L., 1996. A receptor subtype involved in neuropeptide-Y-induced food intake. Nature 382, 168-171.
16. Gero, A., 1983. Desensitization, two-state receptors and pharmacological parameters. J. Theor. Biol. 103, 137-161.
17. Grundemar, L., Wahlestedt, C., Reis, D.J., 1991a. Long-lasting inhibition of the cardiovascular responses to glutamate and the baroreceptor reflex elicited by neuropeptide Y injected into the nucleus tractus solitarius. Neurosci. Lett. 122, 135-139.
18. Grundemar, L., Wahlestedt, C., Reis, D.J., 1991b. Neuropeptide Y acts at an atypical receptor to evoke cardiovascular depression and to inhibit glutamate responsiveness in brainstem. J. Pharmacol. Exp. Ther. 258, 633-638.
19. Grundemar, L., Håkanson, R., 1993. Multiple neuropeptide Y receptors are involved in cardiovascular regulation. Peripheral and central mechanisms. Gen. Pharmacol. 24, 785-796.
20. Grundemar, L., Håkanson, R., 1994. Neuropeptide Y effector systems: Perspectives for drug development. Trends Pharmacol. Sci. 15, 153-159.
21. 3 receptors. Eur. J. Pharmacol. 278, R3-R5.
22. 2 receptor antagonist ketanserin restores the 5-HT-induced contraction depressed by methysergide in large coronary arteries of calf. Naunyn-Schmiedebergs Arch, pharmacol. 328, 295-300.
23. Kostenis, E., Mohr, K., 1996. Two-point kinetic experiments to quantify allosteric effects on radioligand dissociation. Trends Pharmacol. Sci. 17, 280-283.
24. 1 type. J. Biol. Chem. 267, 10935-10938.
25. Lundberg, L.M., Terenius, L., Hokfelt, T., Martling, C.-R., Tatemoto, K., Polak, J., Bloom, S.R., Goldstein, M., 1982. Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol. Scand. 116, 477-480.
26. Lundberg, L.M., Franco-Cereceda, A., Hemsen, A., Lacroix, J.S., 1990. Fundam. Clin. Pharmacol. 4, 373-391.
27. Lundberg, J., Modin, A., Malmström, R.E., 1996. Recent developments with neuropeptide Y receptor antagonists. Trends Pharmacol. Sci. 17, 301-304.
28. Lundell, I., Blomqvist, A.G., Berglund, M.M., Schober, D.A., Johnson, D., Statnick, M.A., Gadski, R.A., Gehlert, D.R., Larhammar, D., 1995. Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY. J. Biol. Chem. 270, 29123-29128.
29. Motulsky, H.J., Mahan, L.C., 1983. The kinetics of competitive radioligand binding predicted by the law of mass action. Mol. Pharmacol. 25, 1-9.
30. O'Donohue, T.L., Cornwall, B.M., Pruss, R.M., Mezey, E., Kiss, J.Z., Eiden, L.E., Massari, V.L., Tessel, R.E., Pickel, V.M., DiMaggio, D.A., 1985. Neuropeptide Y and peptide YY neuronal and endocrine systems. Peptides 6, 755-768.
31. Olins, G.M., Chen, S.T., McMahon, E., Palomo, M.A., Reitz, D.B., 1994. Elucidation of the insurmountable nature of an angiotensin receptor antagonist, SC-54629. Mol. Pharmacol. 47, 115-120.
32. 1 receptor antagonist. Eur. J. Pharmacol. 290, 151-156.
33. 1 receptor antagonist. Br. J. Pharmacol. 107, 1173-1180.
34. Robertson, M.J., Dougall, I.G., Harper, D., Mckechnie, K.C.W., Leff, P., 1994. Agonist-antagonist interactions at angiotensin receptors: Application of a two-state receptor model. Trends Pharmacol. Sci. 15, 364-369.
35. 1 receptor antagonist: BIBP3226. Eur. J. Pharmacol. 271, R11-R13.
36. 2-adrenergic receptor, extending the ternary complex model. J. Biol. Chem. 268, 4625-4635.
37. 1 receptors. Am. Soc. Neurosci. Abstr. 20, 907.
38. 1 receptor antagonist. FEBS Lett. 362, 192-196.
39. Severne, Y., IJzerman, A., Nerme, V., Zimmerman, H., Vauquelin, G., 1986. Shallow agonist competition binding curves for β-adrenergic receptors: The role for tight agonist binding. Mol. Pharmacol. 31, 69-73.
40. Stanley, B.G., Leibowitz, S.F., 1985. Neuropeptide Y injected in the paraventricular hypothalamus: A powerful stimulant of feeding behaviour. Proc. Natl. Acad. Sci. USA 82, 3940-3943.
41. Tatemoto, K., 1982. Neuropeptide Y: The complete amino-acid sequence of the brain peptide. Proc. Natl. Acad. Sci. USA 79, 5485-5489.
42. Tatemoto, K., Mutt, V., 1980. Isolation of two novel candidate hormones using a chemical method for finding naturally occuring polypeptides. Nature 285, 417-418.
43. Tatemoto, K., Carlquist, M., Mutt, V., 1982. Neuropeptide Y: A novel brain peptide with structural similarities to polypeptide YY and pancreatic polypeptide. Nature 296, 659-660.
44. Wahlestedt, C., Reis, D.J., 1993. Neuropeptide Y-related peptides and their receptors: Are the receptors potential therapeutic drug targets?. Annu. Rev. Pharmacol. Toxicol. 32, 309-352.
45. 3-type receptors for neuropeptide Y/peptide YY. Life Sci. 50, PL7-PL12.
46. Walker, P., Grouzmann, E., Burier, M., Waeber, B., 1991. The role of neuropeptide Y in cardiovascular regulation. Trends Pharmacol. Sci. 12, 111-115.
47. Watanabe, N., Kamei, S., Ohkubu, A., Yamanaka, M., Ohsawa, S., Makino, K., Tokuba, K., 1986. Urinary protein as measured with a pyrogallol red-molybdate complex, manually and in Hitachi 726 automated analyser. Clin. Chem. 32, 1551-1554.
48. 3H]propionyl-neuropeptide Y to rat and human frontal cortical membranes. J. Neurochem. 55, 956-962.
49. Wieland, H.A., Willim, K.D., Entzeroth, M., Wienen, W., Rudolf, K., Eberlein, W., Engel, W., Doods, H.N., 1995. Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP3226. J. Pharmacol. Exp. Ther. 275, 143-149.